证券代码：000881 证券简称：中广核技 公告编号：2025-057 中广核核技术发展股份有限公司 独立董事提名人声明与承诺 提名人中广核核技术发展股份有限公司董事会现就提名黄晓延为中广核核 技术发展股份有限公司第十一届董事会独立董事候选人发表公开声明。被提名人 已书面同意作为中广核核技术发展股份有限公司第十一届董事会独立董事候选 人（参见该独立董事候选人声明）。本次提名是在充分了解被提名人职业、学历、 职称、详细的工作经历、全部兼职、有无重大失信等不良记录等情况后作出的， 本提名人认为被提名人符合相关法律、行政法规、部门规章、规范性文件和深圳 证券交易所业务规则对独立董事候选人任职资格及独立性的要求，具体声明并承 诺如下事项： 一、被提名人已经通过中广核核技术发展股份有限公司第十届董事会提名委 员会资格审查，提名人与被提名人不存在利害关系或者其他可能影响独立履职情 形的密切关系。 二、被提名人不存在《中华人民共和国公司法》第一百七十八条等规定不得 担任公司董事的情形。 是 □ 否 如否，请详细说明： 三、被提名人符合中国证监会《上市公司独立董事管理办法》和深圳证券交 易所业务规则规定的独立董事任职资格和条 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-060 中广核核技术发展股份有限公司 独立董事候选人声明与承诺 声明人王满作为中广核核技术发展股份有限公司第十一届董事会独立董事候选人，已充 分了解并同意由提名人中广核核技术发展股份有限公司董事会提名为中广核核技术发展股 份有限公司（以下简称该公司）第十一届董事会独立董事候选人。现公开声明和保证，本 人与该公司之间不存在任何影响本人独立性的关系，且符合相关法律、行政法规、部门规 章、规范性文件和深圳证券交易所业务规则对独立董事候选人任职资格及独立性的要求， 具体声明并承诺如下事项： 一、本人已经通过中广核核技术发展股份有限公司第十届董事会提名委员会资格审查， 提名人与本人不存在利害关系或者其他可能影响独立履职情形的密切关系。 是 □ 否 如否，请详细说明： 二、本人不存在《中华人民共和国公司法》第一百七十八条等规定不得担任公司董事的 情形。 是 □ 否 如否，请详细说明： 三、本人符合中国证监会《上市公司独立董事管理办法》和深圳证券交易所业务规则规 定的独立董事任职资格和条件。 是 □ 否 如否，请详细说明： 五、本人已经参加培训并取得证券交易所 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-064 中广核核技术发展股份有限公司 关于召开 2026 年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或 重大遗漏。 一、召开会议的基本情况 1.股东会届次：2026 年第一次临时股东会 2.股东会的召集人：董事会 3.本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市 规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等法 律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 4.会议时间： （1）现场会议时间：2026 年 1 月 16 日 15:00 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2026 年 1 月 16 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系统投票的 具体时间为 2026 年 1 月 16 日 9:15 至 15:00 的任意时间。 5.会议的召开方式：现场表决与网络投票相结合。 6.会议的股权登记日：2026 年 1 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-067 中广核核技术发展股份有限公司 第十届董事会第三十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 一、董事会会议召开情况 1.中广核核技术发展股份有限公司（以下简称"公司"）第十届董事会第三十 二次会议（以下简称"本次会议"）通知于 2025 年 12 月 26 日以电子邮件形式发 出。 2.本次会议于 2025 年 12 月 29 日下午 15:00 在深圳市福田区深南大道 2002 号中广核大厦北楼 19 层 881 会议室以视频和通讯表决方式召开。 3.本次会议应参加表决董事 9 名，实际参加表决董事 9 名（其中：委托出席 的董事 0 名，董事长盛国福、董事牟文君、于海峰、慕长坤、独立董事黄晓延、 康晓岳以视频方式参会，董事何飞、吴远明、独立董事王满以通讯方式表决）。 4.本次会议由公司董事长盛国福先生主持。公司部分高管人员列席会议。 5.本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 二、董事会会议审议情况 经出席会议的 ...

南财智讯12月30日电，中广核技公告，公司于2025年12月30日收到杨凌浩先生提交的书面辞职报告，杨 凌浩先生由于工作调动，申请辞去公司总会计师、总法律顾问、首席合规官职务，其原定任期为公司第 十届董事会届满为止。辞职后，杨凌浩先生将不在公司担任任何职务。根据《公司法》《公司章程》的 有关规定，杨凌浩先生的辞职报告自送达公司董事会之日起生效。截至本公告披露日，杨凌浩先生未持 有公司股份。 ...

Core Viewpoint - The exhibition "Building a Strong Country Road - Achievements of China's Manufacturing during the 14th Five-Year Plan" showcases significant advancements in China's manufacturing sector, highlighting key technologies such as the "Hualong One" nuclear power technology and proton therapy systems developed by China General Nuclear Power Group (CGN) [1][2] Group 1: Exhibition Overview - The exhibition is co-hosted by the National Museum of China and the Ministry of Industry and Information Technology, running for an estimated five months and featuring over 300 exhibits across six sections [1] - The "Hualong One" nuclear power model is prominently displayed in the "Green Manufacturing" section, emphasizing its role as a national symbol of China's nuclear power capabilities [1] Group 2: Hualong One Nuclear Technology - The "Hualong One" technology can generate nearly 10 billion kilowatt-hours of electricity annually, sufficient to meet the annual electricity needs of 1 million people [1] - This technology has fostered the development of over 5,400 enterprises in the upstream and downstream supply chain and has achieved 100% domestic production capability for its equipment [1] Group 3: Proton Therapy System - The proton therapy system model demonstrates how nuclear technology can enhance public health, with CGN's equipment being included in the Ministry of Industry and Information Technology's directory for major technological equipment promotion [2] - Proton therapy is particularly effective for targeting tumor tissues while minimizing damage to surrounding healthy tissues, making it suitable for pediatric cancer patients [2] Group 4: R&D and Technological Advancements - During the 14th Five-Year Plan, CGN has committed to high-level technological self-reliance, with R&D investment intensity reaching 3.8% by the end of the plan [2] - CGN has achieved significant innovations, including the successful certification of the "Hualong One" technology in the UK and Europe, and the widespread application of the first nuclear-grade digital control system [2] - The company is also advancing in the renewable energy sector, focusing on a "New Energy+" strategy and making progress in the development of solar thermal collectors [2]

Group 1 - The core viewpoint of the article highlights the inauguration of China's first nuclear medical demonstration base at the Suzhou University Affiliated Second Hospital, which integrates nuclear technology for precise diagnosis and treatment, clinical trials, medical innovation, and training [1] - The nuclear medical industry in China is expected to experience accelerated growth due to policy benefits and technological breakthroughs, particularly in the areas of radionuclide preparation, radiopharmaceutical development, and nuclear medical equipment [1] - The Chinese nuclear medical market is projected to maintain rapid growth from 2025 to 2030, with an expected annual output value reaching approximately 600 billion yuan by the end of the 14th Five-Year Plan [1] Group 2 - Companies such as Jingye Intelligent and CGN Technology are mentioned in relation to the nuclear medical sector [2]

Core Viewpoint - The nuclear pollution prevention sector is experiencing significant growth, driven by recent events in Japan that have raised global concerns about nuclear safety and pollution management [1][3]. Company Performance - Companies in the nuclear pollution prevention sector have seen substantial stock price increases, with notable performers including: - Puni Testing (谱尼测试) up 19.95% to 9.32 - Zaiseng Technology (再升科技) up 9.97% to 11.03 - Yinbang Shares (银邦股份) up 5.41% to 13.05 - Guangzhi Technology (光智科技) up 5.23% to 48.27 - Hujiang Materials (沪江材料) up 5.14% to 19.23 [2]. Industry Context - The recent leakage incident at Japan's "Puxian" nuclear reactor, which involved approximately 20 milliliters of radioactive water, has highlighted serious vulnerabilities in Japan's nuclear facility operations and safety regulations [3][4]. - The timing of this incident coincides with Japan's controversial decision to release over 130,000 tons of treated nuclear wastewater from the Fukushima plant, which has sparked significant public opposition and international criticism [4][5]. Market Trends - The nuclear pollution prevention industry is expanding, particularly in China, where the growth of nuclear power plants and advancements in nuclear technology are driving demand for pollution management solutions [6]. - The market for nuclear pollution prevention is expected to grow due to increased concerns about radiation and the need for effective waste management technologies [6]. Sector Segmentation - The nuclear pollution prevention industry can be divided into several segments, including: - Nuclear accident prevention - Nuclear waste treatment - Radiation protection - Decommissioning of nuclear facilities [7]. Relevant Companies and Technologies - Key companies and their technologies in the nuclear pollution prevention sector include: - China General Nuclear Power (中广核技) and China Electric Environmental Protection (中电环保) for nuclear wastewater treatment technologies - Jiarong Technology (嘉戎技术) for membrane separation technology applicable to nuclear wastewater treatment - Hailun Zhe (海伦哲) for biochemical decontamination equipment - Jianlong Micro-Nano (建龙微纳) for specialized molecular sieves for radioactive element removal [8]. - Other notable companies include: - Sun Moon Shares (日月股份) for nuclear storage tank products - Tongyu Heavy Industry (通裕重工) for intelligent nuclear waste treatment equipment - China General Nuclear (中国广核) for nuclear wastewater processing capabilities [8].

12月19日，中广核技（000881）公告称，公司于2025年12月17日接到持股5%以上股东中国大连国际经 济技术合作集团有限公司（简称"国合集团"）函告，获悉国合集团所持有本公司的部分股份被司法再冻 结及轮候冻结。 截至本公告日，国合集团持有本公司118,914,273股，占公司总股本的12.58%，为公司持股5%以上股东 而非控股股东，亦非公司控股股东的一致行动人，其所持公司股份被司法冻结不会影响公司的正常生产 经营。 截至本公告日，国合集团持有公司股份累计被冻结118,914,273股，占其所持有的公司股份的100.00%， 占公司总股本的12.58%。 | 股东名称 持股教量（股） 特股比例 | | --- | 据了解，因金融借款纠纷，大连高新技术产业园区人民法院于12月15日申请将国合集团所持中广核技 14,273股、118,900,000股司法冻结，到期日为2028年12月14日。 12月19日，中广核技（000881）公告称，公司于2025年12月17日接到持股5%以上股东中国大连国际经 济技术合作集团有限公司（简称"国合集团"）函告，获悉国合集团所持有本公司的部分股份被司法再冻 结及轮候冻结 ...

Group 1 - Xusheng Group's actual controller has changed to the Guangzhou Municipal Government, with stock resuming trading on December 23, 2025 [1] - Lingyun Light plans to invest up to $5 million in the IPO of Zhipu Hong Kong as a cornerstone investor [1] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuan Robotics to enhance collaboration in the development of dexterous hands [2] Group 2 - Hualian Holdings intends to acquire 100% of the Canadian company Argentum Lithium S.A. for $175 million, which is approximately 1.235 billion yuan [3] - Shiyuan Zhaoye plans to raise no more than 550 million yuan through a convertible bond issuance for the Zhuhai Shiyuan Jingguan Garden project [4] - ST Quanwei and its subsidiary are involved in a civil mediation agreement involving 69.0158 million yuan [4] Group 3 - Jiao Jian Co.'s actual controller has been subjected to criminal coercive measures, but the company's control has not changed [5] - Tianji Technology is facing a lawsuit for alleged collusion in bidding, but its operations remain normal [5] - Jinpan Technology plans to issue 1.672 billion yuan in convertible bonds for data center power modules and other projects [5] Group 4 - Hongqi Chain's shareholder Yonghui Supermarket plans to reduce its stake by up to 3% [6] - Shuangqiang Technology's director did not implement a planned share reduction [7] - Zhuoran Co.'s subsidiary has signed a significant order worth 4.033 billion yuan [8] Group 5 - ST Zhitong's stock will have its risk warning lifted on December 24, 2025, with a change in trading limits [9] - Yingwei Co. plans to reduce its stake by up to 0.56% [10] - Huaxia Happiness's board rejected five temporary proposals from China Ping An Life Insurance [11] Group 6 - China Nonferrous Metals plans to acquire 99.9% of Raura Company for $106 million [11] - Sanhua Intelligent Control expects a net profit of 3.874 billion to 4.649 billion yuan for 2025, a year-on-year increase of 25% to 50% [11] - Chaoxun Communication received a government subsidy of 18.0455 million yuan [12] Group 7 - Jiangfeng Electronics plans to transfer 4% of Shanghai Runping's equity for 60 million yuan [12] - Dingyang Technology has launched a 20 GHz high-bandwidth digital oscilloscope [13] - Linyi Intelligent plans to acquire 35% of Dongguan Liminda Electronics for 875 million yuan [14] Group 8 - Trina Solar has sold its U.S. 5GW module factory to T1, receiving $100 million in cash and shares [14] - Aihua Packaging's major shareholder reduced its stake by 700,000 shares during the stock's abnormal fluctuation period [14] - China Merchants Bank has approved a comprehensive credit limit of 165 billion yuan for China Merchants Group [15] Group 9 - Lingwei Technology plans to acquire 70% of Jiangsu Huimai for 50.2 million yuan [16] - Yongding Co. is increasing its capital by 600 million yuan for its polysilicon subsidiary [19] - Zhong'an Technology's subsidiary is voluntarily extending its share lock-up period by six months [19] Group 10 - Xiangyu Medical's brain-computer interface products have entered over 500 top-tier hospitals, with a target of 700 by the Spring Festival [18] - Wenda Technology's major shareholder has terminated its share reduction plan [18] - Wenta Technology's major shareholder reduced its stake by 1.2097 million shares [18]